STOCKHOLM, Nov. 18, 2024 /PRNewswire/ -- EQT Life Sciences is pleased to announce that its LSP 7 fund has invested in ATB Therapeutics. The €54 million Series A funding round is aimed at ...

"Nua Surgical's SteriCISION C-Section Retractor has the potential to significantly enhance outcomes for mothers undergoing C-section procedures," said Anne Portwich, Partner at EQT. "We are ...

STOCKHOLM, Nov. 18, 2024 /PRNewswire/ -- EQT Life Sciences is pleased to announce that its LSP 7 fund has invested in ATB Therapeutics. The €54 million Series A funding round is aimed at accelerating ...

"Nua Surgical's SteriCISION C-Section Retractor has the potential to significantly enhance outcomes for mothers undergoing C-section procedures," said Anne Portwich, Partner at EQT. "We are excited to ...

EQT Life Sciences has led the extension, and joins a consortium of prominent global biotechnology investors. The investment builds on EQT Life Sciences' previous successful partnership with ...

Irish maternal health company Nua Surgical secures €6.5M in Series A funding led by EQT Life Sciences SteriCISION is the first self-retaining retractor designed specifically for Caesarean ...

Proceeds will be used to enable key late-stage clinical trial readouts for assets across several underserved neurological diseases with high unmet medical need. EQT Life Sciences has led the extension ...